ketoconazole has been researched along with cancidas in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, JT; Antunes Fernandes, SO; Araújo, LA; Cardoso, VN; Johann, S; Lima, WG; Morais, FB; Prates Silva, MK; Ribeiro Viana, GH; Saldanha, AA; Siqueira Ferreira, JM; Soares, AC; Sousa, JF | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Chaffin, WL; Mekala, S; Perumal, P | 1 |
| Deising, HB; Serfling, A; Wohlrab, J | 1 |
| Calderone, R; Chauhan, N; Kruppa, M | 1 |
| Agarwal, AK; Ashfaq, MK; Babu, KS; Clark, AM; Elsohly, HN; Jacob, MR; Khan, SI; Li, XC; Manly, SP | 1 |
| Jin, LJ; Samaranayake, LP; Samaranayake, YH; Seneviratne, CJ | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Bakker-Woudenberg, IA; Fahal, AH; van Belkum, A; van de Sande, WW | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for ketoconazole and cancidas
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for ketoconazole and cancidas
| Article | Year |
|---|---|
Design, synthesis, and biodistribution studies of new analogues of marine alkaloids: Potent in vitro and in vivo fungicidal agents against Candida spp.
Topics: Alkaloids; Antifungal Agents; Candida; Dose-Response Relationship, Drug; Drug Design; Fungicides, Industrial; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Role for cell density in antifungal drug resistance in Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests | 2007 |
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles | 2007 |
The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Culture Media; Drug Resistance, Fungal; Fluconazole; Histidine Kinase; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrimidines; Signal Transduction; Triazoles; Voriconazole | 2007 |
Potent in vitro antifungal activities of naturally occurring acetylenic acids.
Topics: Alkynes; Animals; Antifungal Agents; Candida albicans; Cell Line; Fatty Acids, Unsaturated; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Rubiaceae; Trichophyton | 2008 |
Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Topics: Antifungal Agents; Biofilms; Candida albicans; Cell Adhesion; Colony Count, Microbial; Culture Media; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Polystyrenes; Time Factors | 2008 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents.
Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Madurella; Micafungin; Microbial Sensitivity Tests; Mycetoma | 2010 |